Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors.
Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors. Transl Androl Urol. 2020 Jan; 9(Suppl 1):S31-S35.